The Cohort Study of Pediatric Cataract

Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05472844
Collaborator
(none)
5,000
1
113.3
44.1

Study Details

Study Description

Brief Summary

This retrospective-prospective bidirectional cohort study aims to observe ocular parameter changes, different surgical/vision recovery strategies and postoperative adverse effects among young children with cataract. The influence on psychology and cognitive function will be taken into consideration as well.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Pediatric cataract, one of the leading causes of childhood blindness globally, is complex and of great difficulty in treatment. Pediatric patients with cataract (congenital, traumatic or complicated) are enrolled. In this study, investigators will compare ocular parameter changes, different surgical/vision timing or recovery strategies and adverse effects among young children (age < 18 yo)before and after cataract surgery. The influence on psychology and cognitive function will be taken into consideration as well. The whole blood samples of participants and parents are collected and retained in our biobank for gene sequencing, hoping to explore the genetic factors in association with pathogenesis. For children received cataract surgery, samples of partial anterior capsular tissue and 1 ml aqueous humor were collected during operation for further analysis. Multimodal artificial intelligence analyses are performed to establish accurate diagnosis/treatment scheme and disease prediction model.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    5000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Cohort Study of Pediatric Cataract
    Anticipated Study Start Date :
    Aug 22, 2022
    Anticipated Primary Completion Date :
    Jan 1, 2032
    Anticipated Study Completion Date :
    Feb 1, 2032

    Outcome Measures

    Primary Outcome Measures

    1. Best-corrected visual acuity changes [Baseline and through study completion, an average of 1 year]

      Best-corrected visual acuity changes are measured by visual acuity charts (Teller/Lea symbol/ETDRS chart) every 1 year at scheduled time

    2. Intraocular pressure changes [Baseline and through study completion, an average of 1 year]

      Intraocular pressures are measured by NCT machine

    3. Refractive power changes [Baseline and through study completion, an average of 1 year]

      Refractive power are measured at baseline and every visit at least every 1 year

    4. Ocular biological measurements changes [Baseline and through study completion, an average of 1 year]

      Ocular biological measurements including axial length, corneal keratometry, anterior chamber angle/depth, corneal endothelial cell number and appearance

    5. Incidence changes of postoperative complications [Baseline and through study completion, an average of 1 year]

      Incidence of postoperative complications, such as glaucoma-related adverse, myopic shift, strabismus and anisometropia and so on

    Secondary Outcome Measures

    1. Other factors changes [Baseline and through study completion, an average of 1 year]

      Sleep, depression, cognitive function are measured by questionnaires. Self-Rating Scale of Sleep: minimum value-1 point, maximum value-50, and higher scores mean worse outcome. Hamilton Depression Scale: <7 points-normal, and higher scores mean worse outcome. Loewenstein Cognitive Assessment: for every question, minimum 1 point, and maximum 4 points. Higher scores mean worse outcomes.

    2. BMI changes [Baseline and through study completion, an average of 1 year]

      BMI is measured by technicians in every visit

    3. Blood pressure changes [Baseline and through study completion, an average of 1 year]

      Diastolic and systolic blood pressure are measured by technicians in every visit

    4. Stereopsis changes [Baseline and through study completion, an average of 1 year]

      Stereopsis is measured by Randot Stereotest

    5. Optical coherence tomography (OCT) changes [Baseline and through study completion, an average of 1 year]

      Retinal thickness is measured and analyzed by OCT

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • aged < 18 yo at the 1st visit unilateral or bilateral cataract agree to participant in this study and sign the informed consent
    Exclusion Criteria:
    • adults

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zhongshan Ophthalmic Center Guangzhou Guangdong China 510060

    Sponsors and Collaborators

    • Zhongshan Ophthalmic Center, Sun Yat-sen University

    Investigators

    • Principal Investigator: Yizhi Liu, PhD, Zhongshan Ophthalmic Center, Sun Yat-sen University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Yizhi Liu, Professor, Zhongshan Ophthalmic Center, Sun Yat-sen University
    ClinicalTrials.gov Identifier:
    NCT05472844
    Other Study ID Numbers:
    • 2022KYPJ099
    First Posted:
    Jul 25, 2022
    Last Update Posted:
    Aug 23, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Yizhi Liu, Professor, Zhongshan Ophthalmic Center, Sun Yat-sen University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 23, 2022